Primerica Inc expected to post earnings of $6.03 a share - Earnings Preview
Primerica Inc expected to post earnings of $6.03 a share - Earnings Preview
Primerica Inc PRI.N, PRI is expected to show a rise in quarterly revenue when it reports results on August 5 for the period ending June 30 2026
The Duluth Georgia-based company is expected to report a 9.7% increase in revenue to $870.606 million from $793.33 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Primerica Inc is for earnings of $6.03 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Primerica Inc is $309.00, about 2.6% below its last closing price of $317.25
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 5.48 | 5.48 | 5.96 | Beat | 8.8 |
Dec. 31 2026 | 5.73 | 5.68 | 6.13 | Beat | 8 |
Sep. 30 2025 | 5.57 | 5.54 | 6.33 | Beat | 14.2 |
Jun. 30 2025 | 5.22 | 5.21 | 5.46 | Beat | 4.8 |
Mar. 31 2025 | 4.79 | 4.78 | 5.02 | Beat | 5 |
Dec. 31 2024 | 5.02 | 4.98 | 5.03 | Beat | 0.9 |
Sep. 30 2024 | 4.81 | 4.78 | 5.68 | Beat | 18.8 |
Jun. 30 2024 | 4.48 | 4.47 | 4.71 | Beat | 5.3 |
This summary was machine generated August 3 at 21:33 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Primerica
See all newsPrimerica, Inc. reports results for the quarter ended September 30 - Earnings Summary
Financial services distributor Primerica's Q3 adjusted EPS beats on investment sales strength
Brief: Primerica Q3 Adjusted EPS USD 6.77 Vs. IBES Estimate USD 6.38
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Primerica, Inc. reports results for the quarter ended June 30 - Earnings Summary